St. Laurent, Canada

Yanick LaFontaine

This inventor holds 1 USPTO granted patent. Top assignee: The Medicines Company. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yanick LaFontaine. Retrieved from https://idiyas.com/inventor/yanick-lafontaine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yanick LaFontaine: Innovator in Antibiotic Development

Introduction

Yanick LaFontaine is a notable inventor based in St. Laurent, Canada. He has made significant contributions to the field of medicine, particularly in the development of antibiotics. His work focuses on addressing critical health issues, such as bone and joint infections.

Latest Patents

LaFontaine holds a patent for "Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections." This invention relates to phosphonated Rifamycins and outlines methods for making and using these compounds. These compounds are particularly useful as antibiotics for the prophylaxis and treatment of bone and joint infections, especially osteomyelitis.

Career Highlights

Yanick LaFontaine is associated with The Medicines Company, where he applies his expertise in antibiotic development. His innovative approach has led to advancements in the treatment of serious infections, showcasing his commitment to improving patient outcomes.

Collaborations

LaFontaine has collaborated with notable colleagues, including Evelyne Dietrich and Ranga Reddy. These partnerships have contributed to the success of his research and the development of effective medical solutions.

Conclusion

Yanick LaFontaine's work in antibiotic innovation highlights his dedication to addressing significant health challenges. His contributions are vital in the ongoing fight against infections, particularly in vulnerable populations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…